��������

Craig has been contributing to Lakeside Life Science since its inception in 2015. He specializes in clinical study design and protocol development, clinical data management, biostatistics, regulatory submissions, and manuscript writing and editing (Craig is a co-author on 90 peer-reviewed publications in the field of oncology and diagnostics). Craig has over 25 years of experience in the in vitro diagnostics industry and was instrumental in the clinical development and validation of the CELLSEARCH system and associated components for the capture and enumeration of circulating tumor cells and the ROMA pelvic mass triage assay. Craig has a BS in Biochemistry from Texas A&M University.